Related Experiment Video
Updated: Feb 1, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Profiling targetable immune checkpoints in osteosarcoma
Troy A McEachron1,2,3, Timothy J Triche2,4, Laurie Sorenson1
1Department of Translational Genomics.
Abstract:
Osteosarcomas are aggressive bone tumors for which therapeutic advances have not improved over several decades. Unlike most pediatric tumors, the osteosarcoma genome is remarkably unstable, characterized by numerous copy number alterations and chromosomal structural aberrations. In this study, we asked if the targetable immune checkpoints CD274 (PD-L1), PDCD1LG2 (PD-L2), CD276 (B7-H3) and IDO1 are impacted by copy number alterations in osteosarcoma. Of the 215 osteosarcoma samples investigated, PD-L1/PD-L2, B7-H3 and IDO1 were independently gained at frequencies of approximately 8-9%, with a cumulative frequency of approximately 24%. RNA sequencing data from two independent cohorts revealed that B7-H3 is the most highly expressed immune checkpoint gene among the four investigated. We also show that IDO1 is preferentially expressed in pediatric solid tumors and that increased protein expression of B7-H3 and IDO1 are significantly associated with inferior survival in patient samples. Using human osteosarcoma cell lines, we demonstrate that IDO1 is gained in MG63 and G292 cells and that the IDO1 inhibitor, epacadostat, inhibits the enzymatic activity of IDO1 in a dose-dependent manner in these cells. Together, these data reveal the genomic and transcriptomic profiles of PD-L1, PD-L2, B7-H3 and IDO1 in osteosarcoma and identifies a potential context for targeted immunotherapeutic intervention in a subset of patients.
Insights
Osteosarcoma tumors show genomic instability impacting immune checkpoints like PD-L1, B7-H3, and IDO1. Increased B7-H3 and IDO1 expression correlates with poorer survival, suggesting potential immunotherapeutic targets.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Osteosarcomas are aggressive bone tumors with limited therapeutic progress.
- Osteosarcoma genomes exhibit significant instability, including copy number alterations and structural aberrations.
Purpose of the Study:
- To investigate the impact of copy number alterations on targetable immune checkpoints (CD274/PD-L1, PDCD1LG2/PD-L2, CD276/B7-H3, IDO1) in osteosarcoma.
- To explore the expression profiles and clinical significance of these immune checkpoints in osteosarcoma.
Main Methods:
- Analysis of genomic copy number alterations in 215 osteosarcoma samples.
- RNA sequencing of two independent osteosarcoma cohorts.
- Protein expression analysis and correlation with patient survival.
- In vitro studies using osteosarcoma cell lines and an IDO1 inhibitor (epacadostat).
Main Results:
- PD-L1/PD-L2, B7-H3, and IDO1 gains occurred in approximately 24% of osteosarcoma samples.
- B7-H3 demonstrated the highest expression among the investigated immune checkpoints.
- Increased B7-H3 and IDO1 protein expression were significantly associated with inferior patient survival.
- IDO1 was preferentially expressed in pediatric solid tumors and its inhibition by epacadostat was confirmed in cell lines.
Conclusions:
- Genomic alterations in immune checkpoints are prevalent in osteosarcoma.
- B7-H3 and IDO1 represent potential therapeutic targets for a subset of osteosarcoma patients.
- These findings highlight a potential avenue for targeted immunotherapeutic interventions in osteosarcoma.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
What is the Immune System?
Humoral Immune Responses
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Taping Over Different Ground Profiles
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...

